| Title |
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
|
|---|---|
| Published in |
Journal of the National Comprehensive Cancer Network (JNCCN), July 2018
|
| DOI | 10.6004/jnccn.2018.0062 |
| Pubmed ID | |
| Authors |
David S Ettinger, Dara L Aisner, Douglas E Wood, Wallace Akerley, Jessica Bauman, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico, Thomas J Dilling, Michael Dobelbower, Ramaswamy Govindan, Matthew A Gubens, Mark Hennon, Leora Horn, Rudy P Lackner, Michael Lanuti, Ticiana A Leal, Rogerio Lilenbaum, Jules Lin, Billy W Loo, Renato Martins, Gregory A Otterson, Sandip P Patel, Karen Reckamp, Gregory J Riely, Steven E Schild, Theresa A Shapiro, James Stevenson, Scott J Swanson, Kurt Tauer, Stephen C Yang, Kristina Gregory, Miranda Hughes |
| Abstract |
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 50% |
| Spain | 1 | 25% |
| Singapore | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 98 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 13 | 13% |
| Student > Ph. D. Student | 12 | 12% |
| Researcher | 12 | 12% |
| Student > Master | 12 | 12% |
| Student > Doctoral Student | 9 | 9% |
| Other | 12 | 12% |
| Unknown | 28 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 37% |
| Biochemistry, Genetics and Molecular Biology | 13 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Engineering | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Other | 4 | 4% |
| Unknown | 34 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#6,460,141
of 25,655,374 outputs
Outputs from Journal of the National Comprehensive Cancer Network (JNCCN)
#665
of 1,746 outputs
Outputs of similar age
#101,864
of 340,888 outputs
Outputs of similar age from Journal of the National Comprehensive Cancer Network (JNCCN)
#12
of 31 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,746 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.2. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,888 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.